2-(3-fluorophenyl)-7-(1-methyl-1H-pyrazol-5-yl)-2H-[1,2,3]triazolo[4,5-f]quinoline-9-carboxylic acid methyl ester | 1287793-41-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 2-(3-fluorophenyl)-7-(1-methyl-1H-pyrazol-5-yl)-2H-[1,2,3]triazolo[4,5-f]quinoline-9-carboxylic acid methyl ester
• 英文别名: Methyl 2-(3-fluorophenyl)-7-(2-methylpyrazol-3-yl)triazolo[4,5-f]quinoline-9-carboxylate
• CAS: 1287793-41-2
• 化学式: C₂₁H₁₅FN₆O₂
• 分子量: 402.388
• InChiKey: XBWHEPNPCBMYHZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  30
• 可旋转键数：
  4
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  87.7
• 氢给体数：
  0
• 氢受体数：
  7

文献信息

• PHARMACEUTICAL COMPOSITION COMPRISING AROMATIC HETEROCYCLIC COMPOUND
  申请人：Takada Chie

  公开号：US20120196854A1

  公开（公告）日：2012-08-02

  A pharmaceutical composition comprising as an active ingredient, an aromatic heterocyclic compound represented by the formula (I): [wherein Q 1 represents CR 2 (wherein R 2 represents a hydrogen atom or the like) or the like; Q 2 represents CR 3 (wherein R 3 represents a hydrogen atom or the like) or the like; Q 3 represents a nitrogen atom or the like; R 1 represents —C(═O)OR 16 (wherein R 16 represents a hydrogen atom or the like) or the like; R 5 represents a hydrogen atom or the like; R 6 represents optionally substituted cycloalkyl or the like; X and Y may be the same or different and each represent CH in which H may be substituted with a substituent or the like; and Z represents a nitrogen atom or the like] or the like is provided.

  提供一种药物组合物，其活性成分为一种芳香杂环化合物，其化学式为（I）：[其中Q1代表CR2（其中R2代表氢原子或类似物）或类似物；Q2代表CR3（其中R3代表氢原子或类似物）或类似物；Q3代表氮原子或类似物；R1代表—C(═O)OR16（其中R16代表氢原子或类似物）或类似物；R5代表氢原子或类似物；R6代表可选择取代的环烷基或类似物；X和Y可以相同也可以不同，并且每个代表CH，其中H可以被取代为取代基或类似物；Z代表氮原子或类似物]或类似物。
• PHARMACEUTICAL PRODUCT CONTAINING AROMATIC HETEROCYCLIC COMPOUND
  申请人：Kyowa Hakko Kirin Co., Ltd.

  公开号：EP2487175A1

  公开（公告）日：2012-08-15

  A pharmaceutical composition comprising as an active ingredient, an aromatic heterocyclic compound represented by the formula (I): [wherein Q1 represents CR2 (wherein R2 represents a hydrogen atom or the like) or the like; Q2 represents CR3 (wherein R3 represents a hydrogen atom or the like) or the like; Q3 represents a nitrogen atom or the like; R1 represents -C(=O)OR16 (wherein R16 represents a hydrogen atom or the like) or the like; R5 represents a hydrogen atom or the like; R6 represents optionally substituted cycloalkyl or the like; X and Y may be the same or different and each represent CH in which H may be substituted with a substituent or the like; and Z represents a nitrogen atom or the like] or the like is provided.

  一种药物组合物，其活性成分包括由式 (I) 代表的芳香杂环化合物： [其中 Q1 代表 CR2（其中 R2 代表氢原子或类似物）或类似物； Q2 代表 CR3（其中 R3 代表氢原子或类似物）或类似物； Q3 代表氮原子或类似物； R1 代表-C(＝O)OR16（其中 R16 代表氢原子或类似物）或类似物；R5代表氢原子或类似物；R6代表任选取代的环烷基或类似物；X和Y可以相同或不同，各自代表CH，其中H可以被取代基取代或类似物取代；Z代表氮原子或类似物]或类似物。